ISPC vs MS
iSpecimen Inc (ISPC) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
MS does not have a complete income-statement cache yet.
ISPC currently screens at market cap $4.4M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the ISPC and MS stock pages for the full models.
Not investment advice.